Fig. 1From: Computational insight to design new potential hepatitis C virus NS5B polymerase inhibitors with drug-likeness and pharmacokinetic ADMET parameters predictionsStructure of the target receptor (hepatitis C virus NS5B RNA polymerase) in complex with dasabuvirBack to article page